Skip to main content
  1. Home
  2. Emerging Tech
  3. Web
  4. News

Boaty McBoatface is about to begin its maiden Antarctic voyage

Add as a preferred source on Google

A high-tech, remotely controlled submarine called Boaty McBoatface is setting out on its first mission in the icy cold waters of Antarctica this week.

As you may recall, the bizarre moniker was the result of a public campaign launched last year by the United Kingdom’s Natural Environment Research Council (NERC) to choose a name for its gleaming new 200 million-pound (about $243 million) polar research ship.

Recommended Videos

The NERC had encouraged “inspirational” suggestions linked to “environmental and polar science, to help us tell everyone about the amazing work the ship does.”

But the council clearly hadn’t accounted for the Brits’ sometimes bonkers humor, with one particular name — Boaty McBoatface — attracting far more votes than any other choice offered in the online poll.

Other suggestions included Onion Knight, I Like Big Boats & I Cannot Lie, and It’s Bloody Cold Here.

Clearly horrified at the thought of having to give its lovely new vessel such a daft name, the NERC reminded everyone that it would have the final say. After some thought, it ended up naming the ship after a British naturalist and broadcaster — a man with the far more sensible name of David Attenborough — who placed fifth in the poll. However, not wanting to completely disregard the people’s carefully considered choice, the council said it’d give the absurd Boaty name to the ship’s robot sub instead.

Boaty gets to work!

This week Boaty McBoatface begins its maiden mission aboard the the British Antarctic Survey research ship RRS James Clark Ross, which the RRS Sir David Attenborough will replace in 2019.

The autonomous underwater vehicle is a 3.62-meter-long, 700-kg “autosub” capable of traveling under ice at depths of up to 6,000 meters. Data gathered by Boaty will be sent back to scientists on the ship via a radio link when the sub periodically surfaces.

“Boaty and similar autonomous vehicles will help oceanographers investigate the processes driving change in the polar regions, including the extent of the ice melt, and conduct a range of research in the Arctic and Antarctic oceans without the need for the constant presence of a research ship,” NERC explains on its website.

In the coming years, Boaty is expected to attempt the first-ever crossing of the Arctic Ocean under ice, a mission that “has the potential to deliver a step-change in scientists’ ability to observe change in this vital region.”

The advantage of the sub’s silly name is that it’s helped to generate publicity for oceanographer’s work far beyond what they could’ve imagined before the public campaign started.

The U.K.’s National Oceanography Centre has even come up with a cartoon version of Boaty McBoatface to get kids interested in marine research, and, according to the Guardian, is also creating a large inflatable of Boaty that’ll publicize its work at special events around Britain.

Trevor Mogg
Contributing Editor
Not so many moons ago, Trevor moved from one tea-loving island nation that drives on the left (Britain) to another (Japan)…
Checking body medication levels may now be as easy as sucking on a peach-flavoured lollipop
Forget the clinic swab; this lollipop wants a lick
Lollylab

Checking your body’s medication levels is usually no one’s idea of fun. Now researchers are trying to change that with Lollylab, a candy-coated, lollipop-like device that can collect saliva and measure levels of acetaminophen in under two minutes.

The prototype created by researchers whose work was published in ACS Sensors transforms a familiar object into a miniature testing device. In a pilot study, six adults ingested the peach-flavored Lollylab before and one hour after a standard 650-milligram dose of acetaminophen. The device repeatedly detected the pain reliever in their saliva, and participants reported it was more comfortable and easier to use than traditional saliva swabs.

Read more
A US state just approved an AI doctor. For now, it’ll only prescribe acne cures.
Aside from acne, Nolla's AI can also handle redness, fine lines and wrinkles, hyperpigmentation and dark spots, and under-eye bags.
Nolla Derm AI doctor app.

The first AI doctor is here. Despite all the skepticism and risks associated with AI models going haywire, the state of Utah just approved Nolla Health, a company that is providing an AI healthcare expert capable of writing prescriptions without any human in the chain. For now, it will only write acne prescriptions for Utah residents over 18 years of age, willing to pay a token monthly subscription fee that's lighter than your Spotify bill.

The big push here is that the Nolla Derm app will reduce the costs of medical consultation, save users the hassle of clinic visits, and take out the problem of waitlisting from the entire healthcare equation. “Unlike telehealth platforms that use AI only to collect information before handing patients off to clinicians, Nolla's AI system is designed to independently issue initial prescriptions within tightly defined, physician-approved treatment protocols,” writes the company. 

Read more
AI’s massive appetite could make cheap smartphones much harder to find
The smartphone aisle is getting pricier, and AI may be partly to blame.
Electronics, Mobile Phone, Phone

Buying a genuinely cheap smartphone could soon become a lot harder, and the reason has little to do with what’s happening inside the smartphone industry itself. The enormous amount of hardware being poured into AI data centers is pressuring global memory supplies. That has helped drive up the cost of making phones, and manufacturers appear increasingly reluctant to absorb those extra costs at the cheapest end of the market.

According to Counterpoint Research, prices of existing smartphones have increased by around 15% globally this year, while newly launched devices are roughly 25% more expensive than comparable models from last year. The impact hasn't been equal everywhere, either. Smartphone prices have climbed 21% in India and 19% across Asia-Pacific, compared with just 5% in the US.

Read more